Arromax Pharmaceutical Technology (Suzhou) Co., Ltd. , located in BioBay of
National High-Tech Industrial Park – Suzhou Industrial Park, is a high-tech enterprise
founded by returned overseas Chinese scholars. Arromax is specialized in innovative R&D
of generic drug synthesis process in areas such as anti-tumor, cardiovascular and diabetes.
It also provides high-quality APIs and their key intermediates.
Arromax has an experienced R&D team with recognition and support from the society.
It has been awarded “Suzhou Engineering Technology Research Center for Small Molecule
Drug R&D” , “Suzhou City and Suzhou Industrial Park Techpioneer” and other titles.
Arromax has developed a series of APIs with the grade of international pharmacopoeia
standards and their key intermediates. It will strive to offer high-quality products and
services to customers all over the world and meet their continuous research needs with the
business philosophy of “ Quality First, Customer Oriented, Faithful Cooperation, Mutual
Benefit” . Arromax sincerely hope to cooperate with you.